FSD Pharma Announces Engagement with Communications Providers and Capital Markets Market Maker | Business


TORONTO – (BUSINESS WIRE) – Sep 22, 2021–

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (” FSD Pharma “or the” Society “), a life sciences holding company dedicated to building a portfolio of biotechnology assets and solutions, today announced that it has retained the services of Hybrid Financial Ltd. (” Hybrid “), North Equities Corp. (the” Northern actions “), Looking Glass Capital Consultants (” Mirror “), Worldwide Media Solutions, LLC (” BGTVDirect “), KCSA Strategic Communications (” KCSA “), and Digi Messaging & Advertising (” Digi “), who will each play a key role in helping the Company improve its market knowledge and foster productive and ongoing dialogues with shareholders and other market participants. Management made this decision following a review deepened the available capital and allocated these resources to investor relations.

Toronto-based Hybrid has been engaged for twelve months, during which time she will be involved in all aspects of a marketing campaign for the company (contract signed August 25, 2021). In consideration for its services, the Company will pay Hybrid a monthly fee of US $ 22,500, which will be paid by issuing 160,714 Hybrid common shares of the Company (“FSD Shares”) at a price equal to US $ 1.68. FSD Shares will be subject to the statutory retention period of four months and one day.

North Equities, also based in Toronto, specializes in various social media platforms and will help the company improve awareness and dissemination of its press releases. North Equities’ commitment is for a period of seven months (contract signed on July 23, 2021). In consideration for its services, the Company agreed to pay North Equities a total fee of 42,918 common shares of the Company (“FSD Shares”) at a price equal to US $ 1.68. FSD Shares will be subject to the statutory retention period of four months and one day.

Looking Glass, which is based in New York, has been hired monthly to help with market awareness for $ 25,000 per month. This contract was signed on June 22, 2021.

BGTV, which is based in Las Vegas, has been hired monthly to help with the company’s multimedia production, programming and news distribution. In consideration for its services, the Company will pay BGTV a monthly royalty of US $ 42,500. This contract was signed on August 8, 2021.

KCSA, a leading New York-based communications company, has committed month-to-month to developing strategic communications. The Company will pay KCSA a monthly fee of USD 25,000. This contract was signed on September 14, 2021.

Digi, who is based in Casper, USA, was hired monthly to help with marketing services. The Company will pay Digi a monthly commission of $ 50,000 and issue to Digi 16,304 FSD Shares at a price equal to $ 1.84. FSD Shares will be subject to the statutory retention period of four months and one day. This contract was signed on August 5, 2021.

Except as described in this press release, none of the Hybrid, North Equities, Looking Glass, BGTV, KCSA and Digi companies have any interest, directly or indirectly, in the Company or its securities, nor no right or intention to acquire such interest. All amounts payable to such advisors will be paid out of the Company’s available working capital.

The Company has also retained the services of Integral Wealth Securities Limited (“ Integral “) to provide market making services. Integral will trade the Company’s shares on the Canadian Securities Exchange in order to maintain an orderly market, improve the liquidity of the Company’s shares and provide the Company with information on Under the terms of the agreement, Integral will receive a fee of $ 6,000 per month for a minimum period of three months. After the initial period of three months, the agreement may be terminated by the Company at any time for a fee 30 days written notice. The Company and Integral are unrelated entities. Integral has no current direct or indirect interest in the Company or its securities. There are no performance factors in the agreement, and Integral will not receive any stock or options as compensation. Integral is a member of the Investment Industry Regulatory Organization of Canada (” IIROC As a result, Integral can access all Canadian stock exchanges and alternative trading systems. The contract for Integral was signed on September 3, 2021. The company has also hired Red Cloud securities for custody services. market on a monthly basis and they will receive a fee of $ 7,000 / month. The Company and Red Cloud are unrelated entities. Red Cloud has no current interest, direct or indirect in the Company or its securities. The contract for Red Cloud titles was signed on September 7, 2021.

About FSD Pharma

FSD Pharma is a life sciences holding company dedicated to building a portfolio of diversified therapeutic assets and innovative health and biotechnology services. Currently, FSD is actively pursuing potential acquisition targets in the health and biotechnology field in order to bring to market innovative treatments to treat various mental health disorders and neurodegenerative diseases.

Forward-looking information

Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “s’ expect ”,“ intend ”,“ may ”,“ should ”and similar expressions as they relate to the Company or its management. Forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward-looking statements, including, but not limited to, statements regarding the terms and deliverables of various agreements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210922006009/en/

CONTACT: For more information:

Zeeshan Saeed, President, Founder and Director, FSD Pharma Inc.

Email: [email protected], Phone: (416) 854-8884

Investor Relations: Email: [email protected], Website: www.fsdpharma.com

KEYWORD: UNITED STATES NORTH AMERICA CANADA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES MENTAL HEALTH HEALTH FINANCING GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: FSD Pharma inc.

Copyright Business Wire 2021.

PUB: 22/09/2021 18:30 / DISC: 22/09/2021 18:32

http://www.businesswire.com/news/home/20210922006009/en


Comments are closed.